Financial Planning & Business Analysis Senior Manager

For the patients, we discover, develop, and manufacture innovative therapies for serious diseases by harnessing the potential of living systems. This approach is based on cutting-edge technologies, such as human genetics, which enable us to understand the molecular mechanisms underlying disease. Amgen focuses its research efforts on conditions where significant unmet medical needs remain. With 18 medicines and numerous collaborative initiatives, Amgen is advancing the treatment of cancer, cardiovascular, inflammatory, and kidney diseases, as well as osteoporosis. With 54 active studies involving 964 patients across 294 centers (2022 figures), France is also one of the countries where Amgen has the most significant clinical research activity. Committed to research and to patients, Amgen is equally committed to its employees. Because we believe in a world where everyone can be themselves and play a meaningful role, Amgen France demonstrates its commitment through its Corporate Social Responsibility program. In 2021, Amgen signed its first LGBT+ Charter and, the following year, was awarded the "Very High Health, Social and Environmental Quality" label, becoming the first pharmaceutical company in France to receive this distinction. We are also proud to have recently signed the Cancer and Employment Charter to support employees affected by illness in maintaining and returning to work.